| Literature DB >> 31627989 |
Minyeong Yoo1, Ngoc-Phuong-Thao Nguyen2, Philippe Soucaille3.
Abstract
Clostridium acetobutylicum has received renewed interest worldwide as a promising producer of biofuels and bulk chemicals such as n-butanol, 1,3-propanediol, 1,3-butanediol, isopropanol, and butyrate. To develop commercial processes for the production of bulk chemicals via a metabolic engineering approach it is necessary to better characterize both the primary metabolism and metabolic regulation of C. acetobutylicum. Here, we review the history of the development of omics studies of C. acetobutylicum, summarize the recent application of quantitative/integrated omics approaches to the physiological analysis and metabolic engineering of this bacterium, and provide directions for future studies to address current challenges.Entities:
Keywords: Clostridium acetobutylicum; biofuels; fluxomics; metabolic engineering; proteomics; systems biology; transcriptomics
Mesh:
Substances:
Year: 2019 PMID: 31627989 DOI: 10.1016/j.tim.2019.09.003
Source DB: PubMed Journal: Trends Microbiol ISSN: 0966-842X Impact factor: 17.079